Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | -0.70% | -14.55% | -24.19% |
22/04 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
12/04 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.19% | 5.72M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.17% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Maxim Group Adjusts Adial Pharmaceuticals Price Target to $3 From $5, Maintains Buy Rating